(Q51781234)
Statements
Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV. (English)
1 reference
Gerald Friedland
1 reference
Saye Khoo
1 reference
Christopher Jack
1 reference
Umesh Lalloo
1 reference
10 October 2006
1 reference
58
1 reference
6
1 reference
1299-1302
1 reference
Identifiers
1 reference